NON-INVASIVE CANCER SOLUTIONS     
Safe | Accurate | Easy on the Patient

WORLDWIDE

Outstanding Benefits for Patients

Outstanding Benefits for Patients

Breast Cancer

  • 39 years old
  • Female patient
  • Cancer had persisted after 5 lines of therapy

Before

Resilient Protocol with Exacta Analysis

After Treatment

Breast Cancer

  • 53 years old
  • Female patient
  • Cancer had persisted after 10 lines of therapy

Before

Resilient Protocol with Exacta Analysis

After Treatment

Ovarian Cancer

  • 48 years old
  • Female patient
  • Cancer had persisted after 3 lines of therapy

Before

Resilient Protocol with Exacta Analysis

After Treatment

Neuroendocrine Tumor of Cervix

  • 41 years old
  • Female patient
  • Cancer had persisted after 4 lines of therapy

Before

Resilient Protocol with Exacta Analysis

After Treatment

Gallbladder Cancer

  • 32 years old
  • Female patient
  • Cancer had persisted after 2 lines of therapy

Before

Resilient Protocol with Exacta Analysis

After Treatment

Leiomyosarcoma

  • 53 years old
  • Female patient
  • Cancer had persisted after 2 lines of therapy

Before

Resilient Protocol with Exacta Analysis

After Treatment

Melanoma

  • 46 years old
  • Female patient
  • Cancer had persisted after 5 lines of therapy

Before

Resilient Protocol with Exacta Analysis

After Treatment

Lung Cancer

  • 62 years old
  • Male patient
  • Cancer had persisted after 4 lines of therapy

Before

Resilient Protocol with Exacta Analysis

After Treatment

Head and Neck Cancer

  • 42 years old
  • Male patient
  • Cancer had persisted after 5 lines of therapy

Before

Resilient Protocol with Exacta Analysis

After Treatment

Head and Neck Cancer

  • 51 years old
  • Male patient
  • Cancer had persisted after 3 lines of therapy

Before

Resilient Protocol with Exacta Analysis

After Treatment

Head and Neck Cancer

  • 65 years old
  • Female patient
  • Cancer had persisted after 3 lines of therapy

Day 0
Day 30
Day 79

CONTACT US

Please contact us for more details.

I have read and understood the terms of use and the privacy policy and I agree.